Q. What are the symptoms of hydrothorax?
Clinical features The presenting symptoms and signs of hepatic hydrothorax are related to direct compression of the adjacent lung. These include cough, shortness of breath, hypoxemia, chest pain and fatigue.
Q. Is malignant pleural effusion always Stage 4?
Stage IV cancer also includes people who have a fluid collection around the lung (called a malignant pleural effusion) caused by the cancer. Stage IV NSCLC cannot be cured, but treatment can reduce pain, ease breathing, and extend and improve quality of life.
Q. Is pleural effusion a death sentence?
The presence of a pleural effusion indicates a high risk of death, with 15% of patients dying within 30 days and 32% dead within one-year of hospital admission.
Q. Will exercise help pleural effusion?
Your doctor may recommend avoiding physical activity while you have pleural effusion or pleurisy. But after treatment, you’ll want to resume normal exercise. High blood pressure increases your risk of pleural effusion.
Q. How can pleural effusion be reduced?
Management and Treatment Diuretics and other heart failure medications are used to treat pleural effusion caused by congestive heart failure or other medical causes. A malignant effusion may also require treatment with chemotherapy, radiation therapy or a medication infusion within the chest.
Q. What is the prognosis for hepatic hydrothorax ( HH )?
The analysis of the data showed that despite the progress of modern hepatology, the presence of HH is associated with poor prognosis and high mortality. Most patients suffering from it are candidates for orthotopic liver transplantation.
Q. Are there any deaths from liver transplants with hydrothorax?
No deaths were reported in the liver transplant group. The data indicate that a substantial number of patients with hepatic hydrothorax had what may be considered atypical presentations, including left-sided only effusions, or pleural effusion without ascites.
Q. What are the most common side effects of PCN?
There were 38% minor complications, including urinary tract infection, catheter dislodgement, catheter obstruction by debris, urinary leakage, and inflammation of the skin at the site of insertion of the percutaneous catheter. Seventy-seven (14%) of the procedures were followed by urinary tract infection during the PCN treatment.
Q. How many PCN’s were successful in a retrospective study?
Using the Seldinger technique, the catheters (6-10 F) were placed under fluoroscopic, ultrasonographic, or CT guidance. Data on underlying disease, complications, subsequent management, and long-term management were collected. Results: PCN was successful in 558 of the 569 attempts (98%).
